Joel Beatty
Stock Analyst at Baird
(4.58)
# 235
Out of 5,161 analysts
211
Total ratings
50.9%
Success rate
34.8%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Maintains: Outperform | $67 → $132 | $80.32 | +64.34% | 4 | Mar 10, 2026 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $14 → $20 | $13.86 | +44.30% | 4 | Mar 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $275 → $433 | $303.37 | +42.73% | 3 | Feb 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Outperform | $72 → $47 | $21.71 | +116.49% | 5 | Dec 30, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $160 → $209 | $180.32 | +15.91% | 5 | Nov 18, 2025 | |
| ELF e.l.f. Beauty | Maintains: Outperform | $145 → $125 | $72.58 | +72.22% | 9 | Nov 6, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Outperform | $10 → $19 | $14.38 | +32.13% | 5 | Oct 16, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Outperform | $10 → $7 | $4.77 | +46.75% | 3 | Sep 30, 2025 | |
| EDIT Editas Medicine | Maintains: Outperform | $4 → $6 | $2.54 | +136.22% | 5 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Neutral | $7 → $9 | $35.33 | -74.53% | 6 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $31 | $21.27 | +45.75% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $38 → $24 | $22.30 | +7.62% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $680 | $708.85 | -4.07% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $29 | $20.70 | +40.10% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $66 | $63.36 | +4.17% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $162 | $154.12 | +5.11% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $27.64 | +48.34% | 3 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $23.39 | +36.81% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $72.25 | +3.81% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $7 | $2.76 | +153.62% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $59.07 | +10.04% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $540 → $240 | $0.33 | +72,495.28% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.60 | +181.25% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $15.61 | +60.15% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $23.99 | +16.72% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.33 | +1,103.01% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.63 | -23.31% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.41 | +3,020.57% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $55.01 | +5.44% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $32.83 | -26.90% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $7.00 | +157.14% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $1.91 | +214.14% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $9.48 | +195.36% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $317.23 | -44.83% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $9.29 | +50.70% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $17.04 | +533.80% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $72.34 | +7.82% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $20.06 | +398.50% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $16.30 | +636.20% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $3.88 | +11,497.94% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.47 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $10.30 | +45.63% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 → $11 | $12.50 | -16.00% | 8 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2,400 → $1,200 | $0.45 | +264,333.67% | 2 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $8.84 | +114.93% | 3 | Nov 10, 2017 |
Dianthus Therapeutics
Mar 10, 2026
Maintains: Outperform
Price Target: $67 → $132
Current: $80.32
Upside: +64.34%
Contineum Therapeutics
Mar 6, 2026
Maintains: Outperform
Price Target: $14 → $20
Current: $13.86
Upside: +44.30%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Outperform
Price Target: $275 → $433
Current: $303.37
Upside: +42.73%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Outperform
Price Target: $72 → $47
Current: $21.71
Upside: +116.49%
Jazz Pharmaceuticals
Nov 18, 2025
Maintains: Outperform
Price Target: $160 → $209
Current: $180.32
Upside: +15.91%
e.l.f. Beauty
Nov 6, 2025
Maintains: Outperform
Price Target: $145 → $125
Current: $72.58
Upside: +72.22%
Amylyx Pharmaceuticals
Oct 16, 2025
Maintains: Outperform
Price Target: $10 → $19
Current: $14.38
Upside: +32.13%
Larimar Therapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $4.77
Upside: +46.75%
Editas Medicine
Aug 13, 2025
Maintains: Outperform
Price Target: $4 → $6
Current: $2.54
Upside: +136.22%
Cogent Biosciences
Jul 8, 2025
Maintains: Neutral
Price Target: $7 → $9
Current: $35.33
Upside: -74.53%
May 19, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $21.27
Upside: +45.75%
May 16, 2025
Downgrades: Neutral
Price Target: $38 → $24
Current: $22.30
Upside: +7.62%
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $708.85
Upside: -4.07%
May 8, 2025
Maintains: Outperform
Price Target: $30 → $29
Current: $20.70
Upside: +40.10%
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $63.36
Upside: +4.17%
May 6, 2025
Maintains: Outperform
Price Target: $160 → $162
Current: $154.12
Upside: +5.11%
May 2, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $27.64
Upside: +48.34%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $23.39
Upside: +36.81%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $72.25
Upside: +3.81%
Nov 15, 2024
Maintains: Outperform
Price Target: $6 → $7
Current: $2.76
Upside: +153.62%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $59.07
Upside: +10.04%
May 15, 2024
Maintains: Outperform
Price Target: $540 → $240
Current: $0.33
Upside: +72,495.28%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.60
Upside: +181.25%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $15.61
Upside: +60.15%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $23.99
Upside: +16.72%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $1.33
Upside: +1,103.01%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.63
Upside: -23.31%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.41
Upside: +3,020.57%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $55.01
Upside: +5.44%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $32.83
Upside: -26.90%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $7.00
Upside: +157.14%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $1.91
Upside: +214.14%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $9.48
Upside: +195.36%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $317.23
Upside: -44.83%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $9.29
Upside: +50.70%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $17.04
Upside: +533.80%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $72.34
Upside: +7.82%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $20.06
Upside: +398.50%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $16.30
Upside: +636.20%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $3.88
Upside: +11,497.94%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $2.47
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $10.30
Upside: +45.63%
Aug 17, 2018
Upgrades: Neutral
Price Target: $14 → $11
Current: $12.50
Upside: -16.00%
Aug 17, 2018
Maintains: Neutral
Price Target: $2,400 → $1,200
Current: $0.45
Upside: +264,333.67%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $8.84
Upside: +114.93%